

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 8.05178824 |
| 2 | viral transcription (GO:0019083) | 5.71003736 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 5.51951281 |
| 4 | translational termination (GO:0006415) | 5.51645885 |
| 5 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 5.19682086 |
| 6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.00130956 |
| 7 | ribosomal small subunit biogenesis (GO:0042274) | 4.91237445 |
| 8 | translational elongation (GO:0006414) | 4.89240611 |
| 9 | cotranslational protein targeting to membrane (GO:0006613) | 4.87568263 |
| 10 | protein targeting to ER (GO:0045047) | 4.87321376 |
| 11 | protein localization to endoplasmic reticulum (GO:0070972) | 4.64578536 |
| 12 | piRNA metabolic process (GO:0034587) | 4.63038109 |
| 13 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.60148565 |
| 14 | behavioral response to nicotine (GO:0035095) | 4.44791556 |
| 15 | ribosomal large subunit biogenesis (GO:0042273) | 4.28121203 |
| 16 | tryptophan metabolic process (GO:0006568) | 4.20381167 |
| 17 | viral life cycle (GO:0019058) | 4.13438670 |
| 18 | indolalkylamine metabolic process (GO:0006586) | 4.12187086 |
| 19 | cellular protein complex disassembly (GO:0043624) | 4.09714173 |
| 20 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.97764586 |
| 21 | kynurenine metabolic process (GO:0070189) | 3.96862496 |
| 22 | vascular smooth muscle contraction (GO:0014829) | 3.90536961 |
| 23 | translational initiation (GO:0006413) | 3.87655322 |
| 24 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.86624509 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.84270485 |
| 26 | histone mRNA catabolic process (GO:0071044) | 3.80667466 |
| 27 | pre-miRNA processing (GO:0031054) | 3.76650974 |
| 28 | inositol phosphate catabolic process (GO:0071545) | 3.73128385 |
| 29 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.71210975 |
| 30 | response to pheromone (GO:0019236) | 3.68064528 |
| 31 | regulation of energy homeostasis (GO:2000505) | 3.54761474 |
| 32 | ncRNA catabolic process (GO:0034661) | 3.51016096 |
| 33 | protein complex disassembly (GO:0043241) | 3.46498375 |
| 34 | neural tube formation (GO:0001841) | 3.46062769 |
| 35 | DNA methylation involved in gamete generation (GO:0043046) | 3.44352311 |
| 36 | polyol catabolic process (GO:0046174) | 3.43116205 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.43094072 |
| 38 | heme biosynthetic process (GO:0006783) | 3.41630444 |
| 39 | L-phenylalanine metabolic process (GO:0006558) | 3.40661411 |
| 40 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.40661411 |
| 41 | kidney morphogenesis (GO:0060993) | 3.39815800 |
| 42 | hyperosmotic salinity response (GO:0042538) | 3.39505063 |
| 43 | detection of light stimulus involved in visual perception (GO:0050908) | 3.38241489 |
| 44 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.38241489 |
| 45 | oxidative phosphorylation (GO:0006119) | 3.38077092 |
| 46 | axoneme assembly (GO:0035082) | 3.34700742 |
| 47 | spinal cord motor neuron differentiation (GO:0021522) | 3.33691864 |
| 48 | respiratory electron transport chain (GO:0022904) | 3.32578318 |
| 49 | fucose catabolic process (GO:0019317) | 3.32553307 |
| 50 | L-fucose metabolic process (GO:0042354) | 3.32553307 |
| 51 | L-fucose catabolic process (GO:0042355) | 3.32553307 |
| 52 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.30409712 |
| 53 | macromolecular complex disassembly (GO:0032984) | 3.24376934 |
| 54 | protein targeting to membrane (GO:0006612) | 3.24054699 |
| 55 | electron transport chain (GO:0022900) | 3.24010143 |
| 56 | protein K11-linked deubiquitination (GO:0035871) | 3.22714828 |
| 57 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.21722992 |
| 58 | microtubule polymerization or depolymerization (GO:0031109) | 3.21675874 |
| 59 | translation (GO:0006412) | 3.20558766 |
| 60 | maturation of SSU-rRNA (GO:0030490) | 3.17712302 |
| 61 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.14562256 |
| 62 | calcium ion import (GO:0070509) | 3.10488567 |
| 63 | ATP synthesis coupled proton transport (GO:0015986) | 3.09742319 |
| 64 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.09742319 |
| 65 | protein complex biogenesis (GO:0070271) | 3.09558960 |
| 66 | heme metabolic process (GO:0042168) | 3.08724240 |
| 67 | regulation of respiratory burst (GO:0060263) | 3.06552022 |
| 68 | photoreceptor cell maintenance (GO:0045494) | 3.05875269 |
| 69 | amine catabolic process (GO:0009310) | 3.05526030 |
| 70 | cellular biogenic amine catabolic process (GO:0042402) | 3.05526030 |
| 71 | neuronal action potential (GO:0019228) | 3.03887915 |
| 72 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.02862601 |
| 73 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.01876277 |
| 74 | cellular ketone body metabolic process (GO:0046950) | 2.98838362 |
| 75 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.97820904 |
| 76 | L-phenylalanine catabolic process (GO:0006559) | 2.97820904 |
| 77 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.96101447 |
| 78 | ubiquinone biosynthetic process (GO:0006744) | 2.95688578 |
| 79 | response to caffeine (GO:0031000) | 2.94342361 |
| 80 | sulfation (GO:0051923) | 2.93183570 |
| 81 | negative regulation of telomere maintenance (GO:0032205) | 2.92004165 |
| 82 | fatty acid transmembrane transport (GO:1902001) | 2.91979723 |
| 83 | sulfur amino acid catabolic process (GO:0000098) | 2.90226193 |
| 84 | meiotic chromosome segregation (GO:0045132) | 2.87037413 |
| 85 | regulation of hexokinase activity (GO:1903299) | 2.85621721 |
| 86 | regulation of glucokinase activity (GO:0033131) | 2.85621721 |
| 87 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.85566963 |
| 88 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.85563087 |
| 89 | gamma-aminobutyric acid transport (GO:0015812) | 2.84749735 |
| 90 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.84403225 |
| 91 | indole-containing compound metabolic process (GO:0042430) | 2.83203808 |
| 92 | pentose metabolic process (GO:0019321) | 2.83136023 |
| 93 | nonmotile primary cilium assembly (GO:0035058) | 2.81193325 |
| 94 | protein-cofactor linkage (GO:0018065) | 2.78869287 |
| 95 | response to interferon-beta (GO:0035456) | 2.78129503 |
| 96 | proline biosynthetic process (GO:0006561) | 2.77078356 |
| 97 | platelet dense granule organization (GO:0060155) | 2.76158788 |
| 98 | ketone body metabolic process (GO:1902224) | 2.75763001 |
| 99 | positive regulation of glycolytic process (GO:0045821) | 2.75314587 |
| 100 | limb bud formation (GO:0060174) | 2.74975392 |
| 101 | histone-serine phosphorylation (GO:0035404) | 2.74543769 |
| 102 | mRNA catabolic process (GO:0006402) | 2.73643924 |
| 103 | regulation of timing of cell differentiation (GO:0048505) | 2.73506910 |
| 104 | protein polyglutamylation (GO:0018095) | 2.73113668 |
| 105 | cytochrome complex assembly (GO:0017004) | 2.72735065 |
| 106 | replication fork processing (GO:0031297) | 2.72725215 |
| 107 | telomere maintenance via recombination (GO:0000722) | 2.71404075 |
| 108 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.70210839 |
| 109 | epithelial cilium movement (GO:0003351) | 2.68700309 |
| 110 | double-strand break repair via homologous recombination (GO:0000724) | 2.68415050 |
| 111 | ubiquinone metabolic process (GO:0006743) | 2.68414674 |
| 112 | cysteine metabolic process (GO:0006534) | 2.68292171 |
| 113 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.67991113 |
| 114 | recombinational repair (GO:0000725) | 2.67789115 |
| 115 | glyoxylate metabolic process (GO:0046487) | 2.66998337 |
| 116 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.66929408 |
| 117 | oxidative demethylation (GO:0070989) | 2.66457875 |
| 118 | histone H2A acetylation (GO:0043968) | 2.66136867 |
| 119 | histone mRNA metabolic process (GO:0008334) | 2.65407291 |
| 120 | DNA demethylation (GO:0080111) | 2.64628483 |
| 121 | kinetochore assembly (GO:0051382) | 2.64137313 |
| 122 | proline transport (GO:0015824) | 2.62756421 |
| 123 | photoreceptor cell development (GO:0042461) | 2.61826899 |
| 124 | DNA strand elongation (GO:0022616) | 2.60204633 |
| 125 | * pteridine-containing compound biosynthetic process (GO:0042559) | 2.59443004 |
| 126 | RNA catabolic process (GO:0006401) | 2.58799731 |
| 127 | mitochondrial calcium ion transport (GO:0006851) | 2.58444489 |
| 128 | DNA double-strand break processing (GO:0000729) | 2.57399477 |
| 129 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.56545678 |
| 130 | regulation of cilium movement (GO:0003352) | 2.55888381 |
| 131 | proteasome assembly (GO:0043248) | 2.55696432 |
| 132 | cornea development in camera-type eye (GO:0061303) | 2.55444359 |
| 133 | rRNA methylation (GO:0031167) | 2.55194875 |
| 134 | meiotic cell cycle (GO:0051321) | 2.54257018 |
| 135 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.53521210 |
| 136 | aromatic amino acid family catabolic process (GO:0009074) | 2.52695813 |
| 137 | low-density lipoprotein particle remodeling (GO:0034374) | 2.51959595 |
| 138 | multicellular organism reproduction (GO:0032504) | 2.51490871 |
| 139 | relaxation of cardiac muscle (GO:0055119) | 2.51119270 |
| 140 | relaxation of smooth muscle (GO:0044557) | 2.50618637 |
| 141 | synaptic transmission, cholinergic (GO:0007271) | 2.49394902 |
| 142 | L-methionine salvage (GO:0071267) | 2.49166185 |
| 143 | L-methionine biosynthetic process (GO:0071265) | 2.49166185 |
| 144 | amino acid salvage (GO:0043102) | 2.49166185 |
| 145 | cell differentiation in spinal cord (GO:0021515) | 2.48427118 |
| 146 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.48296068 |
| 147 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.48296068 |
| 148 | rRNA modification (GO:0000154) | 2.48141313 |
| 149 | regulation of skeletal muscle contraction (GO:0014819) | 2.47422810 |
| 150 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.46749400 |
| 151 | signal peptide processing (GO:0006465) | 2.45716027 |
| 152 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.44173438 |
| 153 | cellular response to zinc ion (GO:0071294) | 2.41909660 |
| 154 | kinetochore organization (GO:0051383) | 2.40861067 |
| 155 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.40328799 |
| 156 | respiratory chain complex IV assembly (GO:0008535) | 2.40078009 |
| 157 | pseudouridine synthesis (GO:0001522) | 2.39767352 |
| 158 | glycine metabolic process (GO:0006544) | 2.38847916 |
| 159 | cellular component biogenesis (GO:0044085) | 2.38672039 |
| 160 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.38242440 |
| 161 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.38242440 |
| 162 | pentose-phosphate shunt (GO:0006098) | 2.38136728 |
| 163 | flavonoid metabolic process (GO:0009812) | 2.37459812 |
| 164 | aldehyde catabolic process (GO:0046185) | 2.36534586 |
| 165 | aerobic respiration (GO:0009060) | 2.35879812 |
| 166 | proline metabolic process (GO:0006560) | 2.35756032 |
| 167 | GDP-mannose metabolic process (GO:0019673) | 2.34829865 |
| 168 | porphyrin-containing compound metabolic process (GO:0006778) | 2.34244450 |
| 169 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.33101454 |
| 170 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.31248403 |
| 171 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.31248403 |
| 172 | NADH dehydrogenase complex assembly (GO:0010257) | 2.31248403 |
| 173 | positive regulation of protein homooligomerization (GO:0032464) | 2.31022623 |
| 174 | valine metabolic process (GO:0006573) | 2.29123777 |
| 175 | ethanol oxidation (GO:0006069) | 2.26004425 |
| 176 | regulation of cholesterol esterification (GO:0010872) | 2.25989746 |
| 177 | tetrapyrrole biosynthetic process (GO:0033014) | 2.24310200 |
| 178 | amino-acid betaine metabolic process (GO:0006577) | 2.24065600 |
| 179 | indolalkylamine catabolic process (GO:0046218) | 2.23702477 |
| 180 | tryptophan catabolic process (GO:0006569) | 2.23702477 |
| 181 | indole-containing compound catabolic process (GO:0042436) | 2.23702477 |
| 182 | mitotic recombination (GO:0006312) | 2.23296825 |
| 183 | formation of translation preinitiation complex (GO:0001731) | 2.21856979 |
| 184 | rRNA processing (GO:0006364) | 2.21410080 |
| 185 | establishment of protein localization to membrane (GO:0090150) | 2.21320904 |
| 186 | inner mitochondrial membrane organization (GO:0007007) | 2.21069508 |
| 187 | protein targeting (GO:0006605) | 2.20795664 |
| 188 | response to nitrosative stress (GO:0051409) | 2.18447196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.74947305 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.63795516 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.50183306 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.27835715 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.18574638 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 3.17652618 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.04630680 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.04600554 |
| 9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.02458758 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.84392231 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.77739532 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.52183928 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.47359870 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.45521621 |
| 15 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.39163030 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.37657479 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.36590607 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.35531059 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.34845423 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 2.34283680 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.33226339 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.31209815 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.28932266 |
| 24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.28919002 |
| 25 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.27769183 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.18257755 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 2.15583558 |
| 28 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.14132112 |
| 29 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13606623 |
| 30 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.12129106 |
| 31 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.11852631 |
| 32 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.04775900 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.98149070 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.97204141 |
| 35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.95500890 |
| 36 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.94625798 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94543833 |
| 38 | * IGF1R_20145208_ChIP-Seq_DFB_Human | 1.94315371 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.93901080 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92326982 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.90277959 |
| 42 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.89704207 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86769882 |
| 44 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.86411132 |
| 45 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.83961515 |
| 46 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.82248413 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.79474268 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.78129683 |
| 49 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.76908351 |
| 50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.76711422 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.76584454 |
| 52 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.76384856 |
| 53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73933963 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.73389891 |
| 55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.72448579 |
| 56 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.71121747 |
| 57 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.71121747 |
| 58 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.70818574 |
| 59 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.69748884 |
| 60 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.68253202 |
| 61 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63663371 |
| 62 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.62084476 |
| 63 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.61129834 |
| 64 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.61077316 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60557114 |
| 66 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.58463479 |
| 67 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57594596 |
| 68 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.57273839 |
| 69 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.54892771 |
| 70 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.54892771 |
| 71 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.53152789 |
| 72 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.52322577 |
| 73 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.51664103 |
| 74 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50759957 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50190138 |
| 76 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49740902 |
| 77 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.49533979 |
| 78 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.48681923 |
| 79 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.48428411 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.47886597 |
| 81 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.47744096 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47263963 |
| 83 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.46458450 |
| 84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45262235 |
| 85 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45219411 |
| 86 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.44623223 |
| 87 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.44032903 |
| 88 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43904900 |
| 89 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.42915959 |
| 90 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.40128955 |
| 91 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.39818962 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39096083 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38794632 |
| 94 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.38681927 |
| 95 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.38623585 |
| 96 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.38426868 |
| 97 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.38266622 |
| 98 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.37854644 |
| 99 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.37854644 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37751798 |
| 101 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.37592201 |
| 102 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36733255 |
| 103 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36570334 |
| 104 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.36263131 |
| 105 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.36121919 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35517117 |
| 107 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.34777000 |
| 108 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34165979 |
| 109 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.32384943 |
| 110 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.32384943 |
| 111 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.32248272 |
| 112 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32094012 |
| 113 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.31616908 |
| 114 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31109835 |
| 115 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.30438209 |
| 116 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30246224 |
| 117 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.28185667 |
| 118 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27907228 |
| 119 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27252797 |
| 120 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.25468678 |
| 121 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.24583038 |
| 122 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24577600 |
| 123 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23132415 |
| 124 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.22905372 |
| 125 | NCOR_22424771_ChIP-Seq_293T_Human | 1.22587987 |
| 126 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.22294590 |
| 127 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22129157 |
| 128 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21064339 |
| 129 | * MYC_22102868_ChIP-Seq_BL_Human | 1.20887931 |
| 130 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20769905 |
| 131 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.20273398 |
| 132 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19777365 |
| 133 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.18967241 |
| 134 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.18221880 |
| 135 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17539257 |
| 136 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17322170 |
| 137 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16491983 |
| 138 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.14904899 |
| 139 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14202626 |
| 140 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.12697796 |
| 141 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.12544096 |
| 142 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.12232806 |
| 143 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11944659 |
| 144 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10826866 |
| 145 | MAF_26560356_Chip-Seq_TH1_Human | 1.10735216 |
| 146 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10246571 |
| 147 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10194438 |
| 148 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09800481 |
| 149 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09570158 |
| 150 | AR_20517297_ChIP-Seq_VCAP_Human | 1.09203522 |
| 151 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09124166 |
| 152 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.09057036 |
| 153 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08987091 |
| 154 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07872095 |
| 155 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07741874 |
| 156 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07336547 |
| 157 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06330568 |
| 158 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05730509 |
| 159 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05104204 |
| 160 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 1.04444587 |
| 161 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.03275399 |
| 162 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01789197 |
| 163 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01730689 |
| 164 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01400167 |
| 165 | MAF_26560356_Chip-Seq_TH2_Human | 1.00516719 |
| 166 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.99711287 |
| 167 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99193487 |
| 168 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98603776 |
| 169 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98298529 |
| 170 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.98064038 |
| 171 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97863090 |
| 172 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96966370 |
| 173 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96565356 |
| 174 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96347591 |
| 175 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95987254 |
| 176 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95868148 |
| 177 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.95828078 |
| 178 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95606520 |
| 179 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95458094 |
| 180 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94869296 |
| 181 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.94409406 |
| 182 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94396600 |
| 183 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93393216 |
| 184 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.93258106 |
| 185 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.93160017 |
| 186 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.93157363 |
| 187 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92330368 |
| 188 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92115990 |
| 189 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.91331645 |
| 190 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91118635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.91129402 |
| 2 | MP0005360_urolithiasis | 3.79715209 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.77011547 |
| 4 | MP0005423_abnormal_somatic_nervous | 3.71180525 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.43974211 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.21543890 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.11512114 |
| 8 | MP0005365_abnormal_bile_salt | 3.05396958 |
| 9 | MP0003724_increased_susceptibility_to | 2.74861969 |
| 10 | MP0005551_abnormal_eye_electrophysiolog | 2.66986595 |
| 11 | MP0003186_abnormal_redox_activity | 2.54070715 |
| 12 | MP0001986_abnormal_taste_sensitivity | 2.52569092 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.52082601 |
| 14 | MP0006072_abnormal_retinal_apoptosis | 2.22585833 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.18132609 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.17698175 |
| 17 | MP0004133_heterotaxia | 2.17052616 |
| 18 | MP0009840_abnormal_foam_cell | 2.16647810 |
| 19 | MP0004145_abnormal_muscle_electrophysio | 2.15534740 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.14741989 |
| 21 | MP0003693_abnormal_embryo_hatching | 2.11639350 |
| 22 | MP0002735_abnormal_chemical_nociception | 2.09474857 |
| 23 | MP0002876_abnormal_thyroid_physiology | 2.08992299 |
| 24 | MP0000685_abnormal_immune_system | 2.03783681 |
| 25 | MP0002102_abnormal_ear_morphology | 2.02077553 |
| 26 | MP0006292_abnormal_olfactory_placode | 1.99979218 |
| 27 | MP0009785_altered_susceptibility_to | 1.99454617 |
| 28 | MP0008872_abnormal_physiological_respon | 1.97093824 |
| 29 | MP0008877_abnormal_DNA_methylation | 1.94903526 |
| 30 | MP0000490_abnormal_crypts_of | 1.93059998 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.90529585 |
| 32 | MP0005253_abnormal_eye_physiology | 1.86069696 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.83802958 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.83753226 |
| 35 | MP0003436_decreased_susceptibility_to | 1.83131912 |
| 36 | MP0005083_abnormal_biliary_tract | 1.79713734 |
| 37 | MP0004043_abnormal_pH_regulation | 1.78439978 |
| 38 | MP0000372_irregular_coat_pigmentation | 1.74634104 |
| 39 | MP0005671_abnormal_response_to | 1.71053548 |
| 40 | MP0001968_abnormal_touch/_nociception | 1.70393124 |
| 41 | MP0005025_abnormal_response_to | 1.69505374 |
| 42 | MP0004957_abnormal_blastocyst_morpholog | 1.69282747 |
| 43 | MP0004084_abnormal_cardiac_muscle | 1.69102024 |
| 44 | MP0005332_abnormal_amino_acid | 1.66693865 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.63877377 |
| 46 | MP0002638_abnormal_pupillary_reflex | 1.61831951 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.61554972 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.61554972 |
| 49 | MP0009379_abnormal_foot_pigmentation | 1.58947453 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.58525407 |
| 51 | MP0009745_abnormal_behavioral_response | 1.54705811 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.54192962 |
| 53 | MP0001666_abnormal_nutrient_absorption | 1.53588440 |
| 54 | MP0003890_abnormal_embryonic-extraembry | 1.50921843 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.50262273 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.50047864 |
| 57 | MP0002736_abnormal_nociception_after | 1.49807613 |
| 58 | MP0005319_abnormal_enzyme/_coenzyme | 1.48938420 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.47378135 |
| 60 | MP0003195_calcinosis | 1.47190139 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 1.45284970 |
| 62 | MP0005451_abnormal_body_composition | 1.44309861 |
| 63 | MP0003252_abnormal_bile_duct | 1.44220548 |
| 64 | MP0008775_abnormal_heart_ventricle | 1.43370790 |
| 65 | MP0004142_abnormal_muscle_tone | 1.43240639 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.42218909 |
| 67 | MP0003868_abnormal_feces_composition | 1.41017986 |
| 68 | MP0001485_abnormal_pinna_reflex | 1.40702345 |
| 69 | MP0003763_abnormal_thymus_physiology | 1.39597991 |
| 70 | MP0008469_abnormal_protein_level | 1.38047843 |
| 71 | MP0001800_abnormal_humoral_immune | 1.37681790 |
| 72 | MP0001764_abnormal_homeostasis | 1.35496668 |
| 73 | MP0005000_abnormal_immune_tolerance | 1.34399706 |
| 74 | MP0001853_heart_inflammation | 1.33727409 |
| 75 | MP0000609_abnormal_liver_physiology | 1.33474209 |
| 76 | MP0003136_yellow_coat_color | 1.33238308 |
| 77 | MP0010329_abnormal_lipoprotein_level | 1.32709917 |
| 78 | MP0010094_abnormal_chromosome_stability | 1.29957284 |
| 79 | MP0009643_abnormal_urine_homeostasis | 1.29806553 |
| 80 | MP0006082_CNS_inflammation | 1.28755873 |
| 81 | MP0009046_muscle_twitch | 1.28330505 |
| 82 | MP0003866_abnormal_defecation | 1.27628539 |
| 83 | MP0002398_abnormal_bone_marrow | 1.27528881 |
| 84 | MP0001845_abnormal_inflammatory_respons | 1.27114683 |
| 85 | MP0006035_abnormal_mitochondrial_morpho | 1.26795579 |
| 86 | MP0005464_abnormal_platelet_physiology | 1.26646112 |
| 87 | MP0002419_abnormal_innate_immunity | 1.26216326 |
| 88 | MP0005646_abnormal_pituitary_gland | 1.26207394 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 1.26130230 |
| 90 | MP0004130_abnormal_muscle_cell | 1.25946350 |
| 91 | MP0002734_abnormal_mechanical_nocicepti | 1.25824099 |
| 92 | MP0002723_abnormal_immune_serum | 1.25239156 |
| 93 | MP0002452_abnormal_antigen_presenting | 1.24044874 |
| 94 | MP0002163_abnormal_gland_morphology | 1.23311736 |
| 95 | MP0000689_abnormal_spleen_morphology | 1.23028610 |
| 96 | MP0002405_respiratory_system_inflammati | 1.21873655 |
| 97 | MP0002938_white_spotting | 1.19865963 |
| 98 | MP0002006_tumorigenesis | 1.19830694 |
| 99 | MP0000383_abnormal_hair_follicle | 1.19527453 |
| 100 | MP0002420_abnormal_adaptive_immunity | 1.18695877 |
| 101 | MP0001819_abnormal_immune_cell | 1.18165503 |
| 102 | MP0002722_abnormal_immune_system | 1.17282227 |
| 103 | MP0004215_abnormal_myocardial_fiber | 1.17259664 |
| 104 | MP0005075_abnormal_melanosome_morpholog | 1.17172586 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16535817 |
| 106 | MP0004036_abnormal_muscle_relaxation | 1.16113479 |
| 107 | MP0009697_abnormal_copulation | 1.13284967 |
| 108 | MP0002272_abnormal_nervous_system | 1.12637880 |
| 109 | MP0000631_abnormal_neuroendocrine_gland | 1.11743860 |
| 110 | MP0000716_abnormal_immune_system | 1.11551610 |
| 111 | MP0003646_muscle_fatigue | 1.10740111 |
| 112 | MP0005058_abnormal_lysosome_morphology | 1.09691118 |
| 113 | MP0001486_abnormal_startle_reflex | 1.09612203 |
| 114 | MP0002429_abnormal_blood_cell | 1.08870301 |
| 115 | MP0005636_abnormal_mineral_homeostasis | 1.08716463 |
| 116 | MP0005387_immune_system_phenotype | 1.07884130 |
| 117 | MP0001790_abnormal_immune_system | 1.07884130 |
| 118 | MP0009763_increased_sensitivity_to | 1.05923673 |
| 119 | MP0001970_abnormal_pain_threshold | 1.05334690 |
| 120 | MP0008058_abnormal_DNA_repair | 1.05145172 |
| 121 | MP0004885_abnormal_endolymph | 1.04837080 |
| 122 | MP0001501_abnormal_sleep_pattern | 1.04549330 |
| 123 | MP0009764_decreased_sensitivity_to | 1.04271276 |
| 124 | MP0008057_abnormal_DNA_replication | 1.02968351 |
| 125 | MP0002095_abnormal_skin_pigmentation | 1.02785444 |
| 126 | MP0002019_abnormal_tumor_incidence | 1.02501414 |
| 127 | MP0000427_abnormal_hair_cycle | 1.01808138 |
| 128 | MP0001873_stomach_inflammation | 1.00652115 |
| 129 | MP0003718_maternal_effect | 1.00183351 |
| 130 | MP0000598_abnormal_liver_morphology | 0.99941133 |
| 131 | MP0000343_altered_response_to | 0.97748581 |
| 132 | MP0004019_abnormal_vitamin_homeostasis | 0.97482800 |
| 133 | MP0005379_endocrine/exocrine_gland_phen | 0.96702863 |
| 134 | MP0002118_abnormal_lipid_homeostasis | 0.95824091 |
| 135 | MP0005084_abnormal_gallbladder_morpholo | 0.95206941 |
| 136 | MP0004924_abnormal_behavior | 0.94126941 |
| 137 | MP0005386_behavior/neurological_phenoty | 0.94126941 |
| 138 | MP0002132_abnormal_respiratory_system | 0.92697551 |
| 139 | MP0004147_increased_porphyrin_level | 0.92064404 |
| 140 | MP0002160_abnormal_reproductive_system | 0.91744854 |
| 141 | MP0003011_delayed_dark_adaptation | 0.91342840 |
| 142 | MP0003077_abnormal_cell_cycle | 0.90829745 |
| 143 | MP0003878_abnormal_ear_physiology | 0.90649617 |
| 144 | MP0005377_hearing/vestibular/ear_phenot | 0.90649617 |
| 145 | MP0002693_abnormal_pancreas_physiology | 0.89430213 |
| 146 | MP0001529_abnormal_vocalization | 0.89313762 |
| 147 | MP0005174_abnormal_tail_pigmentation | 0.88454328 |
| 148 | MP0005220_abnormal_exocrine_pancreas | 0.87714601 |
| 149 | MP0003787_abnormal_imprinting | 0.87178690 |
| 150 | MP0000516_abnormal_urinary_system | 0.86595052 |
| 151 | MP0005367_renal/urinary_system_phenotyp | 0.86595052 |
| 152 | MP0004085_abnormal_heartbeat | 0.86534129 |
| 153 | MP0008961_abnormal_basal_metabolism | 0.86219001 |
| 154 | MP0005266_abnormal_metabolism | 0.85826255 |
| 155 | MP0002653_abnormal_ependyma_morphology | 0.85032798 |
| 156 | MP0002064_seizures | 0.84624785 |
| 157 | MP0005448_abnormal_energy_balance | 0.84312992 |
| 158 | MP0010386_abnormal_urinary_bladder | 0.83695518 |
| 159 | MP0001984_abnormal_olfaction | 0.83419364 |
| 160 | MP0004742_abnormal_vestibular_system | 0.82783529 |
| 161 | MP0005195_abnormal_posterior_eye | 0.82637435 |
| 162 | MP0002067_abnormal_sensory_capabilities | 0.82483584 |
| 163 | MP0002234_abnormal_pharynx_morphology | 0.81382253 |
| 164 | MP0002572_abnormal_emotion/affect_behav | 0.80985537 |
| 165 | MP0001663_abnormal_digestive_system | 0.80642905 |
| 166 | MP0005389_reproductive_system_phenotype | 0.80323909 |
| 167 | MP0001533_abnormal_skeleton_physiology | 0.79716488 |
| 168 | MP0000477_abnormal_intestine_morphology | 0.79523504 |
| 169 | MP0006054_spinal_hemorrhage | 0.79465908 |
| 170 | MP0000858_altered_metastatic_potential | 0.78584008 |
| 171 | MP0000465_gastrointestinal_hemorrhage | 0.77567225 |
| 172 | MP0001324_abnormal_eye_pigmentation | 0.75722514 |
| 173 | MP0005620_abnormal_muscle_contractility | 0.75614412 |
| 174 | MP0005670_abnormal_white_adipose | 0.75163012 |
| 175 | MP0004947_skin_inflammation | 0.75039235 |
| 176 | MP0008007_abnormal_cellular_replicative | 0.75002049 |
| 177 | MP0003453_abnormal_keratinocyte_physiol | 0.74607327 |
| 178 | MP0002090_abnormal_vision | 0.74417933 |
| 179 | MP0005171_absent_coat_pigmentation | 0.74211630 |
| 180 | MP0000538_abnormal_urinary_bladder | 0.73985867 |
| 181 | MP0005376_homeostasis/metabolism_phenot | 0.73891596 |
| 182 | MP0003698_abnormal_male_reproductive | 0.73539383 |
| 183 | MP0000749_muscle_degeneration | 0.71552805 |
| 184 | MP0002277_abnormal_respiratory_mucosa | 0.71280824 |
| 185 | MP0001929_abnormal_gametogenesis | 0.71034646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 5.00694634 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.96202811 |
| 3 | Reticulocytopenia (HP:0001896) | 4.22197440 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.13491007 |
| 5 | Hip dysplasia (HP:0001385) | 4.00416973 |
| 6 | Pancreatic cysts (HP:0001737) | 3.93095789 |
| 7 | Hepatic necrosis (HP:0002605) | 3.87628216 |
| 8 | Carpal bone hypoplasia (HP:0001498) | 3.82333389 |
| 9 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.81110018 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.81110018 |
| 11 | Fetal akinesia sequence (HP:0001989) | 3.77117134 |
| 12 | Pancreatic fibrosis (HP:0100732) | 3.70446334 |
| 13 | Acute necrotizing encephalopathy (HP:0006965) | 3.66883537 |
| 14 | Molar tooth sign on MRI (HP:0002419) | 3.66243578 |
| 15 | Abnormality of midbrain morphology (HP:0002418) | 3.66243578 |
| 16 | Hip contracture (HP:0003273) | 3.60365832 |
| 17 | True hermaphroditism (HP:0010459) | 3.56062333 |
| 18 | Mitochondrial inheritance (HP:0001427) | 3.50836461 |
| 19 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.50463076 |
| 20 | Aplasia of the musculature (HP:0100854) | 3.49828986 |
| 21 | Hepatocellular necrosis (HP:0001404) | 3.46871516 |
| 22 | Acute encephalopathy (HP:0006846) | 3.46359594 |
| 23 | Generalized aminoaciduria (HP:0002909) | 3.42574755 |
| 24 | Congenital stationary night blindness (HP:0007642) | 3.35641312 |
| 25 | Nephronophthisis (HP:0000090) | 3.34684026 |
| 26 | Pallor (HP:0000980) | 3.28477459 |
| 27 | Increased CSF lactate (HP:0002490) | 3.28114053 |
| 28 | Macrocytic anemia (HP:0001972) | 3.25651546 |
| 29 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 3.23931399 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.22309583 |
| 31 | Lipid accumulation in hepatocytes (HP:0006561) | 3.12980304 |
| 32 | Spinal muscular atrophy (HP:0007269) | 3.09428725 |
| 33 | Increased muscle lipid content (HP:0009058) | 3.08423247 |
| 34 | Abnormality of the renal medulla (HP:0100957) | 3.08058464 |
| 35 | Increased intramyocellular lipid droplets (HP:0012240) | 3.07232983 |
| 36 | Broad-based gait (HP:0002136) | 3.06689889 |
| 37 | Poikiloderma (HP:0001029) | 3.06659272 |
| 38 | Abnormality of the renal cortex (HP:0011035) | 3.03709423 |
| 39 | Muscle fiber splitting (HP:0003555) | 3.01344751 |
| 40 | Methylmalonic acidemia (HP:0002912) | 3.01009429 |
| 41 | Exertional dyspnea (HP:0002875) | 3.00040892 |
| 42 | Increased hepatocellular lipid droplets (HP:0006565) | 2.99761763 |
| 43 | Cerebral edema (HP:0002181) | 2.98430871 |
| 44 | Progressive macrocephaly (HP:0004481) | 2.90552604 |
| 45 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.89877316 |
| 46 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.84806160 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.84729930 |
| 48 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.83872008 |
| 49 | Disproportionate short-trunk short stature (HP:0003521) | 2.83582827 |
| 50 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.76853617 |
| 51 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.72364334 |
| 52 | Lactic acidosis (HP:0003128) | 2.70157223 |
| 53 | Diaphragmatic weakness (HP:0009113) | 2.68724241 |
| 54 | Attenuation of retinal blood vessels (HP:0007843) | 2.65043221 |
| 55 | Pustule (HP:0200039) | 2.62989186 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.62549897 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 2.62549897 |
| 58 | Nausea (HP:0002018) | 2.60793750 |
| 59 | Increased serum lactate (HP:0002151) | 2.60536307 |
| 60 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.59686037 |
| 61 | Renal Fanconi syndrome (HP:0001994) | 2.57914480 |
| 62 | Anencephaly (HP:0002323) | 2.57450327 |
| 63 | Short tibia (HP:0005736) | 2.54849346 |
| 64 | Methylmalonic aciduria (HP:0012120) | 2.54752189 |
| 65 | Stridor (HP:0010307) | 2.54683799 |
| 66 | Renal cortical cysts (HP:0000803) | 2.54180108 |
| 67 | Aplastic anemia (HP:0001915) | 2.53940296 |
| 68 | Supernumerary spleens (HP:0009799) | 2.51990242 |
| 69 | Abnormal hemoglobin (HP:0011902) | 2.51925803 |
| 70 | Small hand (HP:0200055) | 2.50166745 |
| 71 | Lethargy (HP:0001254) | 2.48698813 |
| 72 | Abnormality of urine glucose concentration (HP:0011016) | 2.48080559 |
| 73 | Glycosuria (HP:0003076) | 2.48080559 |
| 74 | Intrahepatic cholestasis (HP:0001406) | 2.46026412 |
| 75 | Recurrent bacterial skin infections (HP:0005406) | 2.45965463 |
| 76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.43943195 |
| 77 | Xanthomatosis (HP:0000991) | 2.43498140 |
| 78 | Respiratory failure (HP:0002878) | 2.43368331 |
| 79 | Hyperammonemia (HP:0001987) | 2.43194099 |
| 80 | Limited hip movement (HP:0008800) | 2.43109913 |
| 81 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.39835982 |
| 82 | Barrel-shaped chest (HP:0001552) | 2.39541533 |
| 83 | Type II lissencephaly (HP:0007260) | 2.37309108 |
| 84 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.36664091 |
| 85 | Hyperbilirubinemia (HP:0002904) | 2.35735963 |
| 86 | Tubular atrophy (HP:0000092) | 2.34998013 |
| 87 | Cystic liver disease (HP:0006706) | 2.34121005 |
| 88 | Hypoplasia of the pons (HP:0012110) | 2.32404484 |
| 89 | Prolonged partial thromboplastin time (HP:0003645) | 2.32024629 |
| 90 | Progressive inability to walk (HP:0002505) | 2.31649757 |
| 91 | Hypothermia (HP:0002045) | 2.30777464 |
| 92 | Hyperventilation (HP:0002883) | 2.29997076 |
| 93 | Abnormal drinking behavior (HP:0030082) | 2.29834848 |
| 94 | Polydipsia (HP:0001959) | 2.29834848 |
| 95 | Abnormality of the pons (HP:0007361) | 2.29313513 |
| 96 | Gaze-evoked nystagmus (HP:0000640) | 2.28793373 |
| 97 | Exercise intolerance (HP:0003546) | 2.25710158 |
| 98 | Increased serum ferritin (HP:0003281) | 2.25379194 |
| 99 | Reduced antithrombin III activity (HP:0001976) | 2.24752755 |
| 100 | Hypobetalipoproteinemia (HP:0003563) | 2.23768713 |
| 101 | Nonprogressive disorder (HP:0003680) | 2.22757321 |
| 102 | Pendular nystagmus (HP:0012043) | 2.22268601 |
| 103 | Abnormality of reticulocytes (HP:0004312) | 2.22096681 |
| 104 | Medial flaring of the eyebrow (HP:0010747) | 2.21941361 |
| 105 | Abolished electroretinogram (ERG) (HP:0000550) | 2.21383143 |
| 106 | Chronic hepatic failure (HP:0100626) | 2.20463445 |
| 107 | Ketosis (HP:0001946) | 2.19725299 |
| 108 | Difficulty running (HP:0009046) | 2.19689821 |
| 109 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.18959535 |
| 110 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.18694527 |
| 111 | Inability to walk (HP:0002540) | 2.17539456 |
| 112 | Abnormality of the vocal cords (HP:0008777) | 2.17008830 |
| 113 | Recurrent abscess formation (HP:0002722) | 2.14512747 |
| 114 | Hyperphosphaturia (HP:0003109) | 2.14161557 |
| 115 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.12670876 |
| 116 | Decreased central vision (HP:0007663) | 2.11870201 |
| 117 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.11596741 |
| 118 | Congenital, generalized hypertrichosis (HP:0004540) | 2.11439240 |
| 119 | Metabolic acidosis (HP:0001942) | 2.11165485 |
| 120 | Abnormality of the calf musculature (HP:0001430) | 2.08867805 |
| 121 | Vacuolated lymphocytes (HP:0001922) | 2.08786881 |
| 122 | Thrombocytosis (HP:0001894) | 2.06766821 |
| 123 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.06614051 |
| 124 | Sclerocornea (HP:0000647) | 2.06078167 |
| 125 | Hypoplasia of the odontoid process (HP:0003311) | 2.05162148 |
| 126 | Abnormality of T cell physiology (HP:0011840) | 2.03544177 |
| 127 | Furrowed tongue (HP:0000221) | 2.03454941 |
| 128 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.03353065 |
| 129 | 3-Methylglutaconic aciduria (HP:0003535) | 2.02304065 |
| 130 | Ketoacidosis (HP:0001993) | 2.00991072 |
| 131 | Respiratory difficulties (HP:0002880) | 2.00706346 |
| 132 | Congenital hepatic fibrosis (HP:0002612) | 2.00297238 |
| 133 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.98530119 |
| 134 | Abnormality of alanine metabolism (HP:0010916) | 1.98530119 |
| 135 | Hyperalaninemia (HP:0003348) | 1.98530119 |
| 136 | Hyperlipoproteinemia (HP:0010980) | 1.98100650 |
| 137 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.97789037 |
| 138 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.96992830 |
| 139 | Microcytic anemia (HP:0001935) | 1.96112352 |
| 140 | Hyperglycinuria (HP:0003108) | 1.95779614 |
| 141 | Eczematoid dermatitis (HP:0000976) | 1.94025120 |
| 142 | Abnormality of iron homeostasis (HP:0011031) | 1.93976717 |
| 143 | Proximal tubulopathy (HP:0000114) | 1.93074114 |
| 144 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.92972530 |
| 145 | Absent/shortened dynein arms (HP:0200106) | 1.92880752 |
| 146 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.92880752 |
| 147 | Gowers sign (HP:0003391) | 1.92046773 |
| 148 | Type I transferrin isoform profile (HP:0003642) | 1.91774810 |
| 149 | Tubulointerstitial nephritis (HP:0001970) | 1.90384857 |
| 150 | Petechiae (HP:0000967) | 1.89222725 |
| 151 | Limb-girdle muscle atrophy (HP:0003797) | 1.89125938 |
| 152 | Ragged-red muscle fibers (HP:0003200) | 1.88739473 |
| 153 | Large for gestational age (HP:0001520) | 1.88709474 |
| 154 | Polyuria (HP:0000103) | 1.88535461 |
| 155 | Deep venous thrombosis (HP:0002625) | 1.87570349 |
| 156 | Abnormality of vitamin B metabolism (HP:0004340) | 1.87528776 |
| 157 | Optic disc pallor (HP:0000543) | 1.86985515 |
| 158 | IgM deficiency (HP:0002850) | 1.86598543 |
| 159 | Polycythemia (HP:0001901) | 1.85744300 |
| 160 | Vomiting (HP:0002013) | 1.83958569 |
| 161 | Hypolipoproteinemia (HP:0010981) | 1.82992687 |
| 162 | Abnormal biliary tract physiology (HP:0012439) | 1.81325010 |
| 163 | Bile duct proliferation (HP:0001408) | 1.81325010 |
| 164 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.81006723 |
| 165 | Hypokinesia (HP:0002375) | 1.80581126 |
| 166 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.80055684 |
| 167 | Abnormality of glycine metabolism (HP:0010895) | 1.80055684 |
| 168 | Oral leukoplakia (HP:0002745) | 1.79411980 |
| 169 | Calf muscle hypertrophy (HP:0008981) | 1.79241635 |
| 170 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.78477700 |
| 171 | Fat malabsorption (HP:0002630) | 1.78426846 |
| 172 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.77820223 |
| 173 | Recurrent skin infections (HP:0001581) | 1.76693585 |
| 174 | Abnormality of methionine metabolism (HP:0010901) | 1.76690947 |
| 175 | Hand muscle atrophy (HP:0009130) | 1.76237964 |
| 176 | Postaxial foot polydactyly (HP:0001830) | 1.76190447 |
| 177 | CNS demyelination (HP:0007305) | 1.75198444 |
| 178 | Down-sloping shoulders (HP:0200021) | 1.75174713 |
| 179 | Increased corneal curvature (HP:0100692) | 1.75096617 |
| 180 | Keratoconus (HP:0000563) | 1.75096617 |
| 181 | Abnormality of nucleobase metabolism (HP:0010932) | 1.74890166 |
| 182 | Urticaria (HP:0001025) | 1.74636906 |
| 183 | Abnormality of the intrinsic pathway (HP:0010989) | 1.74310985 |
| 184 | Poor head control (HP:0002421) | 1.74292961 |
| 185 | Prolonged bleeding time (HP:0003010) | 1.73182444 |
| 186 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.72966074 |
| 187 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.70591277 |
| 188 | Delayed CNS myelination (HP:0002188) | 1.70346340 |
| 189 | Chronic otitis media (HP:0000389) | 1.69951859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.24870140 |
| 2 | NME2 | 4.77387220 |
| 3 | BMPR1B | 3.19995244 |
| 4 | PIM2 | 2.89891311 |
| 5 | ADRBK2 | 2.84594506 |
| 6 | BCKDK | 2.80030600 |
| 7 | NUAK1 | 2.68543923 |
| 8 | STK39 | 2.57474631 |
| 9 | ZAK | 2.53443761 |
| 10 | WNK4 | 2.52815742 |
| 11 | TESK2 | 2.43594864 |
| 12 | MAP3K11 | 2.34349544 |
| 13 | OXSR1 | 2.32864277 |
| 14 | ACVR1B | 2.19885858 |
| 15 | TAOK3 | 2.19577530 |
| 16 | MAP4K2 | 2.19273220 |
| 17 | TLK1 | 2.17480395 |
| 18 | FLT3 | 2.16555816 |
| 19 | OBSCN | 2.16410988 |
| 20 | STK16 | 2.16126743 |
| 21 | ERN1 | 2.15457979 |
| 22 | GRK1 | 2.13767056 |
| 23 | MAP4K1 | 2.13263921 |
| 24 | INSRR | 2.02099723 |
| 25 | KDR | 1.99430227 |
| 26 | TEC | 1.96404725 |
| 27 | TNIK | 1.94383431 |
| 28 | WNK3 | 1.93558279 |
| 29 | TBK1 | 1.90630073 |
| 30 | KIT | 1.77176571 |
| 31 | WEE1 | 1.76587226 |
| 32 | TYK2 | 1.69823741 |
| 33 | EIF2AK1 | 1.63437776 |
| 34 | JAK3 | 1.59860319 |
| 35 | MAPK15 | 1.59695236 |
| 36 | BUB1 | 1.56938348 |
| 37 | RPS6KB2 | 1.55983672 |
| 38 | BRSK2 | 1.48559307 |
| 39 | MAP3K4 | 1.47347494 |
| 40 | PHKG1 | 1.43368457 |
| 41 | PHKG2 | 1.43368457 |
| 42 | MKNK2 | 1.39574865 |
| 43 | IKBKE | 1.38796423 |
| 44 | MAP3K7 | 1.37349036 |
| 45 | MARK1 | 1.34819879 |
| 46 | MAPK13 | 1.33142238 |
| 47 | MAP3K6 | 1.32339323 |
| 48 | RPS6KA4 | 1.30551269 |
| 49 | LRRK2 | 1.25690391 |
| 50 | CLK1 | 1.22657870 |
| 51 | MAPK11 | 1.19104523 |
| 52 | BTK | 1.17655578 |
| 53 | PIM1 | 1.17090361 |
| 54 | NEK9 | 1.16596472 |
| 55 | STK3 | 1.13679604 |
| 56 | MATK | 1.13241878 |
| 57 | PKN2 | 1.12884565 |
| 58 | PINK1 | 1.10445366 |
| 59 | ZAP70 | 1.09731193 |
| 60 | STK24 | 1.09713301 |
| 61 | TRIM28 | 1.09376140 |
| 62 | FER | 1.09251209 |
| 63 | TESK1 | 1.07883245 |
| 64 | VRK1 | 1.05634712 |
| 65 | VRK2 | 1.05104577 |
| 66 | IRAK4 | 1.04957734 |
| 67 | CDK19 | 1.04386930 |
| 68 | MAPKAPK3 | 1.04167619 |
| 69 | PBK | 1.02761872 |
| 70 | IKBKB | 1.01368061 |
| 71 | BLK | 1.01188750 |
| 72 | ABL2 | 0.99516597 |
| 73 | PLK2 | 0.98868701 |
| 74 | PNCK | 0.98550253 |
| 75 | EPHA3 | 0.96958848 |
| 76 | NEK2 | 0.95753303 |
| 77 | SCYL2 | 0.94785270 |
| 78 | DYRK3 | 0.94280181 |
| 79 | STK10 | 0.91153397 |
| 80 | PAK3 | 0.91068489 |
| 81 | PRKCE | 0.89572750 |
| 82 | FGFR2 | 0.88028516 |
| 83 | CCNB1 | 0.87954023 |
| 84 | DAPK2 | 0.86848681 |
| 85 | DYRK1B | 0.86668367 |
| 86 | STK11 | 0.86566158 |
| 87 | ADRBK1 | 0.86035439 |
| 88 | MST4 | 0.83552951 |
| 89 | TRIB3 | 0.83100520 |
| 90 | IRAK3 | 0.82959739 |
| 91 | PRKAA2 | 0.82692981 |
| 92 | FGFR4 | 0.82129858 |
| 93 | LYN | 0.81248488 |
| 94 | MAP2K3 | 0.79220033 |
| 95 | CDK8 | 0.78480657 |
| 96 | ILK | 0.77876202 |
| 97 | AURKB | 0.77230925 |
| 98 | MAP2K2 | 0.76113254 |
| 99 | DAPK3 | 0.75770909 |
| 100 | PIK3CG | 0.75763621 |
| 101 | MUSK | 0.75480100 |
| 102 | SYK | 0.75266374 |
| 103 | MYLK | 0.74981625 |
| 104 | EIF2AK3 | 0.74799093 |
| 105 | MAP3K3 | 0.74591018 |
| 106 | CSK | 0.73108500 |
| 107 | CASK | 0.72137521 |
| 108 | PRKAA1 | 0.71454904 |
| 109 | MAP2K7 | 0.70035334 |
| 110 | CSNK1G1 | 0.69913714 |
| 111 | MAP3K14 | 0.69194356 |
| 112 | NME1 | 0.69085852 |
| 113 | DYRK2 | 0.68645438 |
| 114 | MAP3K12 | 0.68483163 |
| 115 | IRAK1 | 0.67259666 |
| 116 | PLK1 | 0.65142431 |
| 117 | PRKG2 | 0.64376694 |
| 118 | PRKCG | 0.64033360 |
| 119 | GRK6 | 0.63815309 |
| 120 | CDK7 | 0.63546772 |
| 121 | AURKA | 0.63530989 |
| 122 | TNK2 | 0.63512691 |
| 123 | MAP2K6 | 0.62506857 |
| 124 | BRAF | 0.62085716 |
| 125 | JAK2 | 0.61778979 |
| 126 | PLK3 | 0.61664069 |
| 127 | CDK4 | 0.61023343 |
| 128 | TGFBR1 | 0.60700343 |
| 129 | TXK | 0.60690134 |
| 130 | TAOK1 | 0.60131369 |
| 131 | RPS6KA5 | 0.59689979 |
| 132 | ERBB3 | 0.59627406 |
| 133 | MAP3K8 | 0.58368171 |
| 134 | CSNK2A1 | 0.58084815 |
| 135 | STK4 | 0.57755569 |
| 136 | CSNK1G2 | 0.56929336 |
| 137 | PLK4 | 0.56860225 |
| 138 | MAPK4 | 0.56580937 |
| 139 | TIE1 | 0.54199651 |
| 140 | CAMKK2 | 0.53604074 |
| 141 | PKN1 | 0.53516786 |
| 142 | MKNK1 | 0.52464138 |
| 143 | TGFBR2 | 0.52396156 |
| 144 | HIPK2 | 0.51683129 |
| 145 | PAK4 | 0.50216851 |
| 146 | TRPM7 | 0.49817121 |
| 147 | PRKACA | 0.49226975 |
| 148 | MST1R | 0.49208553 |
| 149 | STK38L | 0.48732301 |
| 150 | LATS1 | 0.47886522 |
| 151 | RAF1 | 0.47512478 |
| 152 | NLK | 0.47153616 |
| 153 | PTK2B | 0.46458843 |
| 154 | CAMK1 | 0.46363006 |
| 155 | LCK | 0.46307359 |
| 156 | MOS | 0.46307050 |
| 157 | ARAF | 0.45974732 |
| 158 | MAP3K10 | 0.45485985 |
| 159 | CSNK1G3 | 0.44933391 |
| 160 | CAMK2A | 0.44817770 |
| 161 | CDK6 | 0.44204331 |
| 162 | CHEK2 | 0.43666954 |
| 163 | CDC7 | 0.42831900 |
| 164 | TTK | 0.41894947 |
| 165 | PRKCQ | 0.41530884 |
| 166 | TAF1 | 0.41053998 |
| 167 | SGK1 | 0.40831099 |
| 168 | PIK3CA | 0.38680200 |
| 169 | PRKCA | 0.38418094 |
| 170 | CDK3 | 0.37439819 |
| 171 | ATM | 0.35289722 |
| 172 | CSNK1A1 | 0.34298347 |
| 173 | CSNK1A1L | 0.34039722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.38004332 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.62556821 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.55975776 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.47186762 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.25415168 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.24755266 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.23597746 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.11191745 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.10639905 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.05689873 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.01168107 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.00096292 |
| 13 | Sulfur relay system_Homo sapiens_hsa04122 | 1.97968269 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.94683948 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 1.93334180 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.89646983 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.84320545 |
| 18 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.84206518 |
| 19 | Protein export_Homo sapiens_hsa03060 | 1.84021872 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.78469329 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.76521816 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.74993198 |
| 23 | Proteasome_Homo sapiens_hsa03050 | 1.74427395 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.73147059 |
| 25 | Basal transcription factors_Homo sapiens_hsa03022 | 1.69437111 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.65917867 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.57779701 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.53933818 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.53405330 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.52870023 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.52577548 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52340232 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.51497620 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.50810093 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50668733 |
| 36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.50043803 |
| 37 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.48725826 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.46803643 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45283508 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 1.38964656 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38056904 |
| 42 | Circadian rhythm_Homo sapiens_hsa04710 | 1.34223790 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.32256875 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30723808 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.30422500 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.28715596 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.28410158 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.27189325 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.25892784 |
| 50 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.22580790 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.21907398 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21870677 |
| 53 | RNA polymerase_Homo sapiens_hsa03020 | 1.21455642 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 1.20491821 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.19299044 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.17938959 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14628691 |
| 58 | Taste transduction_Homo sapiens_hsa04742 | 1.10331445 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08680514 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.08247214 |
| 61 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07476207 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07402609 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07360893 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05388163 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00590695 |
| 66 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.99603974 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.96936087 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94803853 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93858507 |
| 70 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.93812222 |
| 71 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92213663 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91035432 |
| 73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.90828094 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.90366866 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89578529 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87798901 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.84592245 |
| 78 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.84231257 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83396349 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.83045441 |
| 81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82960043 |
| 82 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82256619 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80406230 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79036677 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77864872 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.76603897 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74606023 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74601377 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74565998 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.73839155 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72697877 |
| 92 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71010041 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70849988 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70605041 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69056594 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.68587204 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65206730 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63447483 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.62325896 |
| 100 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.62270695 |
| 101 | Spliceosome_Homo sapiens_hsa03040 | 0.62164316 |
| 102 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.61793445 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60957057 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60174607 |
| 105 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.59793511 |
| 106 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57980963 |
| 107 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57760440 |
| 108 | Legionellosis_Homo sapiens_hsa05134 | 0.57088749 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56317973 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56006245 |
| 111 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55707884 |
| 112 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54695186 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.54385547 |
| 114 | GABAergic synapse_Homo sapiens_hsa04727 | 0.53701644 |
| 115 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53534184 |
| 116 | Morphine addiction_Homo sapiens_hsa05032 | 0.52628124 |
| 117 | Insulin secretion_Homo sapiens_hsa04911 | 0.52091700 |
| 118 | Asthma_Homo sapiens_hsa05310 | 0.51159382 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51003631 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49109528 |
| 121 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.47423089 |
| 122 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46952522 |
| 123 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46403516 |
| 124 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45305243 |
| 125 | Purine metabolism_Homo sapiens_hsa00230 | 0.44546639 |
| 126 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43948859 |
| 127 | Cell cycle_Homo sapiens_hsa04110 | 0.43833307 |
| 128 | RNA degradation_Homo sapiens_hsa03018 | 0.42049781 |
| 129 | RNA transport_Homo sapiens_hsa03013 | 0.40585428 |
| 130 | Allograft rejection_Homo sapiens_hsa05330 | 0.39907279 |
| 131 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.38783838 |
| 132 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35021854 |
| 133 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34565947 |
| 134 | Measles_Homo sapiens_hsa05162 | 0.34182516 |
| 135 | Other glycan degradation_Homo sapiens_hsa00511 | 0.33771804 |
| 136 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.33329576 |
| 137 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31724004 |
| 138 | Salivary secretion_Homo sapiens_hsa04970 | 0.31418306 |
| 139 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30692824 |
| 140 | Lysine degradation_Homo sapiens_hsa00310 | 0.30544210 |

